Matthew Hershenhorn

Stock Analyst at Oppenheimer

(2.59)
# 2,274
Out of 4,981 analysts
1
Total ratings
100%
Success rate
16.03%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $118.42
Upside: +56.22%